Return to content in this issue

 

Successful subcutaneous desensitization to certolizumab

Peñalver MJ MD, Bautista-Villanueva S MD, Barranco R MD, Crespo JF MD PhD, Mielgo R MD

Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol. 34(4)
doi: 10.18176/jiaci.0981

Key words: TNFα inhibitor, Certolizumab, Hypersensitivity, Desensitization, Allergy